Difficulty: Medium
Average Score: 63%
Practice
Severe cases of bleeding due to fibrinolytic agents are treated with
Correct answer
C
Rationale
In severe cases of bleeding due to fibrinolytic agents, the treatment of choice is EACA (Epsilon Amino Caproic Acid) because it inhibits fibrinolysis by blocking the activation of plasminogen to plasmin. This helps in stabilizing blood clots and controlling bleeding.
A) Aspirin is a platelet aggregation inhibitor and is not indicated for treating bleeding caused by fibrinolytic agents.
B) Heparin is an anticoagulant that works by preventing the formation of blood clots but does not directly inhibit fibrinolysis.
D) Vitamin K is essential for the synthesis of clotting factors in the liver but is not used to treat bleeding caused by fibrinolytic agents.
Educationally, understanding the mechanism of action of EACA in inhibiting fibrinolysis is crucial for healthcare professionals managing patients with bleeding disorders. It emphasizes the importance of targeted therapies in specific clinical scenarios to achieve optimal patient outcomes. Remembering the unique role of each drug in managing bleeding disorders helps in making informed and effective treatment decisions.
A) Aspirin is a platelet aggregation inhibitor and is not indicated for treating bleeding caused by fibrinolytic agents.
B) Heparin is an anticoagulant that works by preventing the formation of blood clots but does not directly inhibit fibrinolysis.
D) Vitamin K is essential for the synthesis of clotting factors in the liver but is not used to treat bleeding caused by fibrinolytic agents.
Educationally, understanding the mechanism of action of EACA in inhibiting fibrinolysis is crucial for healthcare professionals managing patients with bleeding disorders. It emphasizes the importance of targeted therapies in specific clinical scenarios to achieve optimal patient outcomes. Remembering the unique role of each drug in managing bleeding disorders helps in making informed and effective treatment decisions.